These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

995 related items for PubMed ID: 8144998

  • 1. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
    McCarthy JT, Williams AW, Johnson WJ.
    J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
    [Abstract] [Full Text] [Related]

  • 2. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M, Haufe CC, Eismann U, Deppisch RM, Stein G, Wolf G.
    Blood Purif; 2007 Apr; 25(5-6):432-40. PubMed ID: 17957097
    [Abstract] [Full Text] [Related]

  • 3. Continuous ambulatory peritoneal dialysis vs haemodialysis: a lesser risk of amyloidosis?
    Tielemans C, Dratwa M, Bergmann P, Goldman M, Flamion B, Collart F, Wens R.
    Nephrol Dial Transplant; 1988 Apr; 3(3):291-4. PubMed ID: 3140103
    [Abstract] [Full Text] [Related]

  • 4. Beta 2-microglobulin levels in patients with renal insufficiency.
    Acchiardo S, Kraus AP, Jennings BR.
    Am J Kidney Dis; 1989 Jan; 13(1):70-4. PubMed ID: 2643313
    [Abstract] [Full Text] [Related]

  • 5. Beta2-microglobulin amyloidosis in hemodialysis and peritoneal dialysis patients.
    Dervisoglu E, Anik Y, Erdogan S, Akansel G, Yilmaz A.
    Ther Apher Dial; 2008 Aug; 12(4):306-10. PubMed ID: 18789118
    [Abstract] [Full Text] [Related]

  • 6. Beta 2-microglobulin serum concentration and associated amyloidosis in dialysis patients.
    Stein G, Schneider A, Thoss K, Ritz E, Schaefer K, Hüller M, Sperschneider H, Marzoll I.
    Nephrol Dial Transplant; 1991 Aug; 6 Suppl 3():57-61. PubMed ID: 1775270
    [Abstract] [Full Text] [Related]

  • 7. Dialysis arthropathy, beta 2-microglobulin and the effect of dialyser membrane.
    Sethi D, Gower PE.
    Nephrol Dial Transplant; 1988 Aug; 3(6):768-72. PubMed ID: 3147418
    [Abstract] [Full Text] [Related]

  • 8. Beta 2 microglobulin in CAPD.
    Montenegro J, Martínez I, Saracho R, González R.
    Adv Perit Dial; 1992 Aug; 8():369-72. PubMed ID: 1361825
    [Abstract] [Full Text] [Related]

  • 9. Behavior of beta 2-microglobulin in patients with chronic renal failure undergoing hemodialysis, hemodiafiltration and continuous ambulatory peritoneal dialysis (CAPD).
    Blumberg A, Bürgi W.
    Clin Nephrol; 1987 May; 27(5):245-9. PubMed ID: 3297439
    [Abstract] [Full Text] [Related]

  • 10. [Amyloidosis associated with chronic hemodialysis. The prognostic significance of beta 2-microglobulin changes in patients with terminal chronic kidney failure treated by repeated hemodialysis].
    Manasia M, Meseşan M, Gherman-Căprioară M, Malide D, Paţiu IM, Pârvu L, Vlăduţiu D, Spânu CS.
    Med Interna; 1991 May; 43(1-2):129-34. PubMed ID: 1670118
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Significance of serum levels of beta-2-microglobulin in dialysis patients].
    Baldrati L, Baldrati L, Delvecchio C, Capponcini C, Docci D, Turci F, Feletti C.
    Recenti Prog Med; 1990 Sep; 81(9):561-3. PubMed ID: 2263750
    [Abstract] [Full Text] [Related]

  • 13. Beta-2-microglobulin in hemodialysis patients. Effects of different dialyzers and different dialysis procedures.
    Mayer G, Thum J, Woloszczuk W, Graf H.
    Am J Nephrol; 1988 Sep; 8(4):280-4. PubMed ID: 3055992
    [Abstract] [Full Text] [Related]

  • 14. [Beta-2 microglobulin and amyloid osteoarthropathy in patients undergoing chronic hemodialysis].
    Prinseau J, Baglin A, Benoit J, Leparc JM, Got C, Louis MF, Attar B, Fritel D.
    Ann Med Interne (Paris); 1989 Sep; 140(2):94-8. PubMed ID: 2662855
    [Abstract] [Full Text] [Related]

  • 15. The effects of reprocessing cuprophane and polysulfone dialyzers on beta 2-microglobulin removal from hemodialysis patients.
    Petersen J, Moore RM, Kaczmarek RG, Singh B, Yeh I, Hamburger S, Kankam M.
    Am J Kidney Dis; 1991 Feb; 17(2):174-8. PubMed ID: 1992659
    [Abstract] [Full Text] [Related]

  • 16. Dialysis related amyloidosis: a disease of chronic retention and inflammation?
    Floege J, Schäffer J, Koch KM, Shaldon S.
    Kidney Int Suppl; 1992 Oct; 38():S78-85. PubMed ID: 1405384
    [Abstract] [Full Text] [Related]

  • 17. Long-term complications of dialysis: pathogenic factors with special reference to amyloidosis.
    Gejyo F, Homma N, Arakawa M.
    Kidney Int Suppl; 1993 Jun; 41():S78-82. PubMed ID: 8320951
    [Abstract] [Full Text] [Related]

  • 18. [Serum beta 2-microglobulin concentration and its removal in patients treated with continuous ambulatory peritoneal dialysis].
    Kubo H, Kawaguchi Y, Aizawa S, Morita T, Nakayama M, Wakabayashi Y, Watanabe S, Ogawa A, Sakai O.
    Nihon Jinzo Gakkai Shi; 1990 Apr; 32(4):419-26. PubMed ID: 2198365
    [Abstract] [Full Text] [Related]

  • 19. [Influence of cuprophane membrane surface dialyzers on beta2-microglobulin serum concentration in patients during hemodialysis].
    Szepietowski T, el-Hayek A.
    Polim Med; 1993 Apr; 23(3-4):43-54. PubMed ID: 8029157
    [Abstract] [Full Text] [Related]

  • 20. Detection of novel beta 2-microglobulin in the serum of hemodialysis patients and its amyloidogenic predisposition.
    Ogawa H, Saito A, Oda O, Nakajima M, Chung TG.
    Clin Nephrol; 1988 Sep; 30(3):158-63. PubMed ID: 3052955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.